Navigation Links
China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Date:8/19/2007

-- Revenues increase 28% to $8.9 Million for Q2 of 2007 versus $7 Million

for Q2 of 2006 -- Gross profit increases 18% to $2.2 Million for Q2 of 2007 versus $1.9

Million for Q2 of 2006 -- Announces LOI to Restructure $11.5 Million of Debt to Equity and Acquire

Remaining 49% of Erye

BEIJING, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, today announced its results for the second quarter ended June 30, 2007.

Revenue for the three months ended June 30, 2007 increased 28% to $8.9 million compared to $7 million for the period ended June 30, 2006. The increase in revenues was mainly attributable to the 31% revenue growth of the Company's subsidiary Erye Pharmaceutical Limited Company ("Erye"). Additionally, the Company realized a full quarter of revenue this year from Enshi as opposed to last year when the acquisition of Enshi was made.

Recent industry developments in China have provided Erye a great opportunity to continue to grow its core business going forward. The Chinese government has invested billions of dollars in a new insurance policy called "Cooperative Medicare." This policy is aimed at providing insurance for farmers in China. Erye will provide their products, which are currently focused on middle-end to low-end markets, to these farmers under the new policy.

Cost of goods sold increased 31% to $6.7 million for the second quarter of 2007 compared to $5.1 million for the second quarter of 2006. Cost of goods sold as a percentage of sales revenues was approximately 75% for the three months ended June 30, 2007 compared to 74% for the three months ended June 30, 2006. The increase in cost of goods sold has remained consistent with the growth of sales for th
'/>"/>

SOURCE China Biopharmaceuticals Holdings, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. How do you level the playing field with China?
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SoundConnect , an award winning ... to announce the addition of Adobe Connects Learning ... tools to quickly deploy and manage online courses ... for desktop and mobile learning solutions. , Adobe ... online training solution, enabling organizations to deploy, measure, ...
(Date:7/30/2014)... 30, 2014 Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... highlights for the quarter ended June 30, 2014 on ... close. Regulus will host a conference ... 5:00 pm Eastern Daylight Time to discuss its second ...
(Date:7/30/2014)... 30, 2014 A study presented at ... and efficacy of CSL Behring,s C1 Inhibitor (C1-INH) ... in highly sensitized patients. C1-INH is a human ... system. The study shows that post-transplant ... the levels of complement components 3 and 4, ...
(Date:7/30/2014)... Selexis SA , a serial ... and mammalian cell line development, announced today new data ... be presented at the 10th Annual Cell Line ... – 10, 2014 at the Double Tree by Hilton ... abstract will be presented during an oral presentation: , ...
Breaking Biology Technology:SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3
... Medco Health,Solutions, Inc. (NYSE: MHS ) Chairman ... members of his senior management team, will present an,overview ... and institutional investors during its annual Analyst Day,conference on ... of Pharmacy," is scheduled to begin at 8 a.m. ...
... Abercrombie, Pfizer R&D Head Martin,Mackay, HHS Deputy Secretary Tevi ... Agenda at FDA/CMS Summit 2007, WASHINGTON, Nov. 15 ... drug approvals. Unfortunately for the biopharma sector and,investors, it,s ... on track,to grant marketing approval to 18 or fewer ...
... Brad Thompson, President,and CEO of Oncolytics Biotech Inc. ... of the company at Toronto CFA Society on ... at the National Club, 303 Bay,Street, Toronto at ... Oncolytics is a Calgary-based biotechnology company focused on ...
Cached Biology Technology:Medco to Webcast Annual Analyst Day Conference 2So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market 2So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market 3Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society 2
(Date:7/30/2014)... a massive collection of 20-million-year-old amber found in the ... effort is yielding fresh insights into ancient tropical insects ... is fully curated, a task that will take many ... collection in the world, the researchers report. , ... of a pygmy locust, a tiny grasshopper the size ...
(Date:7/30/2014)... of Engineering recently received a $330,000 award from ... synthesis of organic nanorods." , According to ... and utilization of functional materials, devices, and systems ... in scaling up nanotechnology is the lack of ... one device. A research team led by Dr. ...
(Date:7/30/2014)... Wallerian degeneration is a subject of major interest ... differentially regulated during the distinct stages of Wallerian ... differentiation and dedifferentiation. Although gene expression responses in ... peripheral nerve injury are known, differences in gene ... unclear. Dr. Dengbing Yao and co-workers from Nantong ...
Breaking Biology News(10 mins):Decades-old amber collection offers new views of a lost world 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... ON (September 05, 2011) You may think your lack ... because you,re lazy, but McMaster University researchers have discovered it ... made their unexpected finding while working with healthy, specially-bred mice, ... exercise removed. The genes control the protein AMP-activated protein kinase ...
... It is now widely accepted that the species Homo ... world. But did those early humans interbreed with more ... erectus, the "upright walking man," Homo habilis, the ... cave-painting fame? Direct studies of ancient DNA from ...
... Ten variants of the deadly Escherichia coli ... sequenced across the world. The unprecedented level of collaboration ... the outbreak arose, says a scientist at the Society ... the bacterium started in early June at BGI, China. ...
Cached Biology News:McMaster researchers find missing genes may separate coach potato from active cousin 2Ancient humans were mixing it up 2Ancient humans were mixing it up 3Ancient humans were mixing it up 4Crowd-sourcing the E. coli O104:H4 outbreak 2
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... This reagent has been developed ... for the reduction of nonspecific background ... Traditional methods describe blocking peroxidase with ... hydrogen peroxide in combination with additional ...
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544...
Biology Products: